A significant portion of the global population lacks access to needed medicines due to the prohibitive costs, compromising individual health and well-being. Generics play a crucial role in expanding healthcare accessibility by offering quality pharmaceuticals at a fraction of the cost, increasing the broader availability of essential medications.
Dr. Reddy’s generic formulation business seeks to address this pressing issue by providing over 200 high-quality generic alternatives to costly innovator medicines. These affordable alternatives are made available in more than 20 countries worldwide, ensuring widespread access to essential healthcare solutions.
The manufacturing team at Dr. Reddy’s delivers medicine affordability by overseeing the entire value chain, from producing active ingredients to streamlined distribution. Their expertise in regulations and intellectual property facilitates the global accessibility of high-quality, regulatory-compliant medicines.
Generic Formulations—including tablets, capsules, injectables, and topical creams—is the largest part of Dr. Reddy’s portfolio, which is meeting the unmet patient needs in the areas of gastroenterology, cardiovascular, diabetology, oncology, pain management, and dermatology.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Generics, Brand Name, Biotech
